Every night, the online Belgian patent register ('eRegister') receives an update with public data that were entered or generated the preceding day on the Benelux Patent Platform, the computer application with which the Belgian Intellectual Property Office handles the registration, treatment and publication processes for patents and supplementary protection certificates.
Currently, some updates are spread over consecutive nights due to the large, weekly volume of data concerning European patents designating Belgium.
For a European patent it is possible that data about the inventor(s) are missing from the online Belgian patent register. They can be found via the link to the European patent register pending an update of the Belgian patent register.
For European patents with Unitary Effect, the authentic source of information is the European Patent Register : please refer to it.

Patent details

2150613 Title: RÉOVIRUS MUTANTS ET LEURS PROCÉDÉS DE FABRICATION ET D'UTILISATION

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic information

Application number:
087483343
WO application number:
CA2008000964
Type:
European patent granted for BE
Status:
Deemed Void
Publication number:
2150613
WO publication number:
WO2008141448
1rst applicant's nationality:
Translation language:
EPO publication language:
English
SPC number:

Dates

Filing date:
21/05/2008
Grant date:
19/10/2016
EP publication date:
10/02/2010
WO publication date:
27/11/2008
Claims translation received date:
Translation received date (EP publication B1):
Translation received date (EP publication B2):
Translation received date (EP publication B3):
Registration date:
19/10/2016
EP B1 publication date:
19/10/2016
EP B2 publication date:
EP B3 publication date:
Lapsed date:
Expiration date (if granted and all annual fees paid):
21/05/2028

Applicant

Name:
Oncolytics Biotech, Inc.
Legal Form:
From:
19/10/2016
Address:
Suite 210, 1167 Kensington Crescent N.W., Calgary, Alberta T2N 1X7, Canada (CA)
To:

Inventor

1

Name:
COFFEY, Matthew C.
Legal Form:
Address:
Calgary, Alberta T2N 3L4, Canada (CA)

2

Name:
THOMPSON, Bradley G.
Legal Form:
Address:
Calgary, Ontario T2N 0Z5, Canada (CA)

Priority

Priority patent number:
939255 P
Priority date:
21/05/2007
Priority country:
United States (US)

Classification

IPC or IDT classification:
C12N 7/01; A61K 35/76; A61P 35/00; C07K 14/14; C12N 15/86; C12N 15/46;

Publication

European Patent Bulletin

Issue number:
201642
Publication date:
19/10/2016
Description:
Grant (B1)

Annual fee

Annual fee(s) Due Date:
31/05/2017
Annual fee number:
10
Annual fee amount:
185 Euro
Expected payer:
Last annual fee payment date:
Last annual fee paid number:
Payer:
Filing date Document type Publication Type Document Description Number of pages File Type